Holen Sie sich die Stockscreener-App
119.32
0.01%
-0.0406
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CLX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$119.36
Offen:
$118.16
24-Stunden-Volumen:
660.50K
Relative Volume:
0.28
Marktkapitalisierung:
$14.43B
Einnahmen:
$7.10B
Nettoeinkommen (Verlust:
$824.00M
KGV:
18.29
EPS:
6.5244
Netto-Cashflow:
$761.00M
1W Leistung:
+5.35%
1M Leistung:
+12.39%
6M Leistung:
-4.42%
1J Leistung:
-19.59%
1-Tages-Spanne:
$118.16
$120.49
1-Wochen-Bereich:
$111.33
$120.87
52-Wochen-Spanne:
$96.66
$159.04
Clorox Co Stock (CLX) Company Profile
Firmenname
Clorox Co
Sektor
Telefon
(510) 271-7000
Adresse
THE CLOROX COMPANY, OAKLAND, CA
Compare CLX vs PG, UL, CL, EL, KVUE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLX
Clorox Co
|
119.31 | 14.43B | 7.10B | 824.00M | 761.00M | 6.5244 |
|
PG
Procter Gamble Co
|
157.29 | 369.91B | 85.26B | 16.53B | 14.85B | 6.7488 |
|
UL
Unilever Plc Adr
|
71.14 | 157.57B | 64.99B | 6.71B | 6.53B | 2.74 |
|
CL
Colgate Palmolive Co
|
93.89 | 76.10B | 20.38B | 2.26B | 3.63B | 2.6214 |
|
EL
Estee Lauder Cos Inc
|
98.28 | 35.98B | 14.67B | -178.00M | 1.14B | -0.5002 |
|
KVUE
Kenvue Inc
|
18.09 | 34.74B | 15.01B | 1.43B | 1.63B | 0.744 |
Clorox Co Stock (CLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-01 | Bestätigt | Barclays | Underweight |
| 2025-01-07 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-11-06 | Hochstufung | TD Cowen | Sell → Hold |
| 2024-10-01 | Hochstufung | Jefferies | Hold → Buy |
| 2024-07-23 | Eingeleitet | TD Cowen | Sell |
| 2024-06-24 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2024-04-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-03-26 | Hochstufung | Jefferies | Underperform → Hold |
| 2024-03-01 | Fortgesetzt | Goldman | Sell |
| 2024-02-05 | Herabstufung | DA Davidson | Buy → Neutral |
| 2023-12-15 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-11-22 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-11-13 | Eingeleitet | Jefferies | Underperform |
| 2023-11-06 | Hochstufung | UBS | Sell → Neutral |
| 2023-11-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-10-12 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2023-10-05 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-10-02 | Hochstufung | DA Davidson | Neutral → Buy |
| 2023-09-22 | Eingeleitet | HSBC Securities | Hold |
| 2023-08-03 | Hochstufung | Atlantic Equities | Underweight → Neutral |
| 2023-02-17 | Eingeleitet | Citigroup | Neutral |
| 2022-10-18 | Eingeleitet | Evercore ISI | Underperform |
| 2022-10-17 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2022-09-14 | Fortgesetzt | BofA Securities | Underperform |
| 2022-07-13 | Eingeleitet | Raymond James | Outperform |
| 2022-02-04 | Herabstufung | Atlantic Equities | Neutral → Underweight |
| 2022-02-04 | Bestätigt | Deutsche Bank | Hold |
| 2022-02-04 | Bestätigt | JP Morgan | Underweight |
| 2022-02-04 | Bestätigt | Morgan Stanley | Underweight |
| 2022-02-04 | Bestätigt | UBS | Sell |
| 2022-02-04 | Bestätigt | Wells Fargo | Underweight |
| 2022-02-02 | Herabstufung | Bernstein | Mkt Perform → Underperform |
| 2022-01-26 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2021-11-02 | Bestätigt | DA Davidson | Neutral |
| 2021-11-02 | Bestätigt | Deutsche Bank | Hold |
| 2021-11-02 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-11-02 | Bestätigt | Wells Fargo | Underweight |
| 2021-09-03 | Herabstufung | Argus | Buy → Hold |
| 2021-08-04 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2021-08-04 | Bestätigt | Citigroup | Buy |
| 2021-08-04 | Bestätigt | Credit Suisse | Neutral |
| 2021-08-04 | Bestätigt | Deutsche Bank | Hold |
| 2021-08-04 | Bestätigt | Morgan Stanley | Underweight |
| 2021-08-04 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2021-08-04 | Bestätigt | UBS | Sell |
| 2021-08-04 | Bestätigt | Wells Fargo | Underweight |
| 2021-06-24 | Eingeleitet | UBS | Sell |
| 2021-05-03 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2021-03-18 | Herabstufung | DA Davidson | Buy → Neutral |
| 2021-02-19 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2021-01-20 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-12-14 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-10-16 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-06-30 | Eingeleitet | DA Davidson | Buy |
| 2020-03-19 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2020-03-16 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2020-03-09 | Hochstufung | Argus | Hold → Buy |
| 2019-10-03 | Bestätigt | BofA/Merrill | Neutral |
| 2019-09-23 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2019-05-20 | Herabstufung | Argus | Buy → Hold |
| 2019-05-02 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-02 | Hochstufung | Deutsche Bank | Sell → Hold |
| 2019-04-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2019-03-07 | Eingeleitet | Credit Suisse | Outperform |
| 2018-12-06 | Bestätigt | BofA/Merrill | Neutral |
| 2018-09-25 | Hochstufung | Argus | Hold → Buy |
| 2018-07-18 | Herabstufung | Goldman | Neutral → Sell |
| 2018-04-19 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-02-08 | Herabstufung | Argus | Buy → Hold |
| 2018-01-04 | Hochstufung | BofA/Merrill | Underperform → Neutral |
Alle ansehen
Clorox Co Aktie (CLX) Neueste Nachrichten
The Clorox Company $CLX Shares Sold by Nuance Investments LLC - MarketBeat
The Clorox Company (CLX): A bull case theory - MSN
Clorox (CLX) Is Consistent, Says Jim Cramer - Finviz
Clorox (NYSE:CLX) Rating Increased to Hold at Wall Street Zen - MarketBeat
BofA flags margin uncertainty for Clorox (CLX) after Q2 earnings miss - MSN
The Clorox Company $CLX Shares Sold by BI Asset Management Fondsmaeglerselskab A S - MarketBeat
Clorox Posts Mixed Quarterly Results Amid Strategic Acquisition - AD HOC NEWS
TD Cowen Issues Positive Forecast for Clorox (NYSE:CLX) Stock Price - MarketBeat
BofA Flags Margin Uncertainty for Clorox (CLX) After Q2 Earnings Miss - Insider Monkey
Clorox Weighs GOJO Deal And ERP Payoff For Growth Reboot - simplywall.st
Morgan Stanley Increases Clorox (NYSE:CLX) Price Target to $136.00 - MarketBeat
The Clorox Company $CLX Stake Lifted by Ashton Thomas Private Wealth LLC - MarketBeat
Clorox Stock Scrubs Out Its Stain: Is This Household Giant Finally Turning the Corner? - AD HOC NEWS
Clorox to Present at 2026 CAGNY Conference - Finviz
Clorox completes $580 million ERP overhaul to link operations with digital commerce - Digital Commerce 360
Clorox Completes U.S, Canada ERP Upgrade - Consumer Goods Technology
UBS Raises Price Target for Clorox (CLX) Amidst Neutral Rating | - GuruFocus
Citigroup Raises Clorox (CLX) Price Target to $115.00, Maintains Neutral Rating | CLX Stock News - GuruFocus
Akron’s GOJO Industries is ‘strong, strategic fit’ with Clorox, CEO says - Signal Akron
Is Clorox’s ERP Strain And GOJO Deal Altering The Investment Case For Clorox (CLX)? - simplywall.st
CLX Analyst Rating Update: JP Morgan Maintains Neutral, Raises P - GuruFocus
Clorox (CLX) Analyst Rating: Evercore Lowers Price Target | CLX Stock News - GuruFocus
Deutsche Bank Aktiengesellschaft Issues Pessimistic Forecast for Clorox (NYSE:CLX) Stock Price - MarketBeat
Clorox (NYSE:CLX) Price Target Cut to $151.00 by Analysts at Jefferies Financial Group - MarketBeat
Clorox (NYSE:CLX) Price Target Raised to $117.00 at JPMorgan Chase & Co. - MarketBeat
Jefferies & Co Adjusts Clorox Price Target to $151 From $152, Maintains Buy Rating - marketscreener.com
The Clorox Company (NYSE:CLX) Q2 2026 Earnings Call Transcript - Insider Monkey
Why Is Clorox Stock Falling Wednesday?Clorox (NYSE:CLX) - Benzinga
CLX Q4 Deep Dive: Flat Sales Amid Margin Pressure as Clorox Invests in Innovation and Integration - Finviz
Clorox Q2 2026 Earnings: EPS $1.29, Revenue $1.67B | Fiscal ResultsNews and Statistics - IndexBox
Clorox Co (CLX) Q2 2026 Earnings Call Highlights: Navigating Challenges with Strategic Innovation and Growth Plans - GuruFocus
Decoding Clorox Co (CLX): A Strategic SWOT Insight - GuruFocus
The Clorox Company (CLX): A Bull Case Theory - Insider Monkey
Clorox's (NYSE:CLX) Q4 CY2025: Beats On Revenue - Finviz
Clorox: Fiscal Q2 Earnings Snapshot - theheraldreview.com
Clorox to Acquire GOJO Industries, Makers of Purell® - cmmonline.com
Clorox (CLX) misses Q2 earnings estimates - MSN
Clorox (CLX) Q2 Earnings Miss Expectations, Revenue Surpasses Es - GuruFocus
Earnings call transcript: Clorox Q2 2026 sees mixed results and stock dip - Investing.com
Transforming our operations: Clorox completes ERP rollout across US and Canada - The Clorox Company
Clorox Posts Lower Profit on Sales Volume Declines - The Wall Street Journal
Clorox’s (NYSE:CLX) Q4 CY2025: Beats On Revenue - The Globe and Mail
Clorox: Overview of Fiscal Second Quarter Earnings - Bitget
CLOROX CO /DE/ SEC 10-Q Report - TradingView
Clorox Earnings Review: Q2 Summary - Benzinga
Clorox (NYSE:CLX) Posts Earnings Results, Misses Expectations By $0.07 EPS - MarketBeat
Clorox shares slip 2% as Q2 earnings miss overshadows revenue beat, driven by higher costs - Investing.com Nigeria
Chair and CEO Linda Rendle on Q2 earnings and outlook for FY26 - The Clorox Company
Clorox misses quarterly profit estimates on muted demand for its cleaning products, higher costs - Reuters
Layoff Watch: What are Cyclerion Therapeutics Inc.’s technical support levelsJuly 2025 Sentiment & Short-Term High Return Ideas - baoquankhu1.vn
Clorox Reports Q2 Fiscal Year 2026 Results, Confirms Outlook - Yahoo Finance
Finanzdaten der Clorox Co-Aktie (CLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):